At Arizona Neuroscience Research (ANR) in Phoenix, we are dedicated to advancing migraine treatment through cutting-edge clinical research. We are now enrolling qualified participants in two exciting Phase 3 clinical trials evaluating a drug for the prevention of both Chronic Migraine and Episodic Migraine.
Migraines can be life-disrupting—causing throbbing head pain, nausea, sensitivity to light and sound, and more. Whether they occur a few times a month or more than half the days each month, migraines can affect work, relationships, and overall quality of life. These studies aim to discover if a new drug, a highly purified botulinum toxin type A already approved for other medical uses, can safely and effectively reduce the number of migraine days you experience.
If you are 18 or older, have been diagnosed with chronic migraine (15+ headache days per month) or episodic migraine (up to 14 headache days per month), and your first migraines began before age 50, you may qualify.
Participants may receive:
Study-related care at no cost
Study medication at no cost
Compensation for time and travel (if applicable)
Help us move migraine research forward and take an active role in your care.
Contact ANR today to see if you qualify.
Call: (480) 210-8723
Email: info@azneuroscienceresearch.com
Help Advance Migraine Research – Enroll Today
Arizona Neuroscience Research is seeking participants for two migraine prevention clinical trials studying Chronic Migraine and Episodic Migraine.
See If You Qualify:
Call Us: (480) 210-8723
or : Contact - Arizona Neuroscience Research - Contact Details
Find more information on the studies by clicking the links below:
Episodic Migraines
Chronic Migraines
More Information:
Migraines are more than just headaches—they can cause throbbing pain, nausea, light and sound sensitivity, and can last for hours or even days. They affect millions of Americans each year, with women 20–50 most commonly impacted.
Types of Migraines:
Chronic Migraine: Headache on 15+ days per month for at least 3 months, with at least 8 days having migraine symptoms.
Episodic Migraine: Headache on 0–14 days per month.
Both can cause:
Throbbing head/face pain (often one-sided)
Sensitivity to light, sound, or smell
Nausea or vomiting
Auras (visual disturbances)
Brain fog & fatigue
Dizziness or vertigo
You may qualify if:
For Chronic Migraine:
Age 18+
Diagnosed with chronic migraine (15+ headache days/month)
First migraines before age 50
For Episodic Migraine:
Age 18+
Diagnosed with episodic migraine (0–14 headache days/month)
First migraines before age 50
Study Duration: ~1 year
Visits: Up to 14 visits (8 may be virtual)
Treatment: Injections every 12 weeks
Tracking: Daily headache diary via smartphone app (device provided if needed)
Study-related care at no cost
Study medication at no cost
Possible compensation for time and travel
Contribution to advancing migraine research
Joining is easy:
Contact us to discuss eligibility.
Attend a screening visit.
Begin study participation.
📍 Locations:
4400 N 32nd St, Suite 150, Phoenix, AZ 85018
3805 E Bell Rd, Suite 2400, Phoenix, AZ 85032
Call: (480) 210-8723
Email: info@azneuroscienceresearch.com